review article | Q7318358 |
scholarly article | Q13442814 |
P50 | author | Jan Górski | Q11717641 |
Arend Bonen | Q123180159 | ||
Joost J F P Luiken | Q98613653 | ||
Adrian Chabowski | Q30902432 | ||
Jan F.C. Glatz | Q43747758 | ||
P2860 | cites work | Role of long-chain fatty acyl-CoA esters in the regulation of metabolism and in cell signalling | Q24530119 |
A family of fatty acid transporters conserved from mycobacterium to man | Q24681246 | ||
Enhanced Sarcolemmal FAT/CD36 Content and Triacylglycerol Storage in Cardiac Myocytes From Obese Zucker Rats | Q27832088 | ||
Contraction-Induced Fatty Acid Translocase/CD36 Translocation in Rat Cardiac Myocytes Is Mediated Through AMP-Activated Protein Kinase Signaling | Q27832095 | ||
Cardiac substrate uptake and metabolism in obesity and type-2 diabetes: Role of sarcolemmal substrate transporters | Q27887268 | ||
Prolonged AMPK Activation Increases the Expression of Fatty Acid Transporters in Cardiac Myocytes and Perfused Hearts | Q27887311 | ||
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase | Q28215845 | ||
Fatty acids in cell signalling: modulation by lipid binding proteins | Q28303482 | ||
Intracellular fatty acid-binding proteins: putting lower vertebrates in perspective | Q28305942 | ||
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus | Q28344691 | ||
A novel function for fatty acid translocase (FAT)/CD36: involvement in long chain fatty acid transfer into the mitochondria | Q28564952 | ||
Fatty acid transport by vectorial acylation in mammals: roles played by different isoforms of rat long-chain acyl-CoA synthetases | Q28566986 | ||
The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR | Q28571566 | ||
Fatty acid transport and FAT/CD36 are increased in red but not in white skeletal muscle of ZDF rats | Q28573303 | ||
Pharmacokinetics and metabolism of 123I-BMIPP fatty acid analog in healthy and CD36-deficient subjects | Q74068054 | ||
Changes in FAT/CD36, UCP2, UCP3 and GLUT4 gene expression during lipid infusion in rat skeletal and heart muscle | Q74202216 | ||
Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats | Q74371834 | ||
Palmitate transport and fatty acid transporters in red and white muscles | Q77189445 | ||
Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles | Q77840434 | ||
A short-term, high-fat diet up-regulates lipid metabolism and gene expression in human skeletal muscle | Q78829955 | ||
Fatty acid transporter levels and palmitate oxidation rate correlate with ejection fraction in the infarcted rat heart | Q79224445 | ||
Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats | Q93514955 | ||
Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis | Q28576005 | ||
Inactivation of fatty acid transport protein 1 prevents fat-induced insulin resistance in skeletal muscle | Q28586493 | ||
FATP1 is an insulin-sensitive fatty acid transporter involved in diet-induced obesity | Q28588041 | ||
Requirement for the heart-type fatty acid binding protein in cardiac fatty acid utilization | Q28593304 | ||
The role of the peroxisome proliferator-activated receptor alpha pathway in pathological remodeling of the diabetic heart. | Q30341823 | ||
Improvement in cardiac function and free fatty acid metabolism in a case of dilated cardiomyopathy with CD36 deficiency | Q31440119 | ||
Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia | Q31629115 | ||
How are free fatty acids transported in membranes? Is it by proteins or by free diffusion through the lipids? | Q33783971 | ||
3T3 fibroblasts transfected with a cDNA for mitochondrial aspartate aminotransferase express plasma membrane fatty acid-binding protein and saturable fatty acid uptake | Q33875742 | ||
Characterization of a heart-specific fatty acid transport protein | Q34173725 | ||
PPAR signaling in the control of cardiac energy metabolism | Q34204732 | ||
Expression cloning and characterization of a novel adipocyte long chain fatty acid transport protein | Q34325172 | ||
A critical role for PPARalpha-mediated lipotoxicity in the pathogenesis of diabetic cardiomyopathy: modulation by dietary fat content. | Q34330003 | ||
A new concept of cellular uptake and intracellular trafficking of long-chain fatty acids | Q34449774 | ||
Fatty acid transport: the roads taken | Q34491580 | ||
Mechanism of cellular uptake of long-chain fatty acids: Do we need cellular proteins? | Q35024407 | ||
Myocardial recovery from ischemia is impaired in CD36-null mice and restored by myocyte CD36 expression or medium-chain fatty acids | Q35144409 | ||
Fatty acid homeostasis in the normoxic and ischemic heart | Q35531455 | ||
New concepts of cellular fatty acid uptake: role of fatty acid transport proteins and of caveolae. | Q35855938 | ||
Role of fatty acid metabolites in the development of myocardial ischemic damage | Q35932942 | ||
A novel mouse model of lipotoxic cardiomyopathy | Q36016938 | ||
Fatty acid metabolism is enhanced in type 2 diabetic hearts | Q36132785 | ||
Myocardial substrate metabolism in the normal and failing heart | Q36179008 | ||
Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle | Q36274041 | ||
Yeast acyl-CoA synthetases at the crossroads of fatty acid metabolism and regulation | Q36517725 | ||
How fatty acids of different chain length enter and leave cells by free diffusion | Q36531065 | ||
Regulation of sarcolemmal transport of substrates in the healthy and diseased heart. | Q36660426 | ||
Is membrane transport of FFA mediated by lipid, protein, or both? An unknown protein mediates free fatty acid transport across the adipocyte plasma membrane | Q36731989 | ||
Exercise, MAPK, and NF-kappaB signaling in skeletal muscle | Q36736877 | ||
Is membrane transport of FFA mediated by lipid, protein, or both? Mechanisms and regulation of protein-mediated cellular fatty acid uptake: molecular, biochemical, and physiological evidence | Q36753522 | ||
Defect in human myocardial long-chain fatty acid uptake is caused by FAT/CD36 mutations | Q73881616 | ||
Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction | Q73975423 | ||
Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice | Q74061464 | ||
Lipotoxic heart disease in obese rats: implications for human obesity | Q37117677 | ||
Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport | Q37670096 | ||
Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. | Q38321475 | ||
Developmental cardiac metabolism in health and disease | Q38700986 | ||
Arsenite modulates cardiac substrate preference by translocation of GLUT4, but not CD36, independent of mitogen-activated protein kinase signaling | Q40279462 | ||
A CD36 nonsense mutation associated with insulin resistance and familial type 2 diabetes | Q40540988 | ||
Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. | Q40810534 | ||
Regulation of energy substrate metabolism in the diabetic heart | Q41526636 | ||
Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes | Q41875562 | ||
AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. | Q42508162 | ||
A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translation | Q42653520 | ||
Evolution of the family of intracellular lipid binding proteins in vertebrates | Q42690586 | ||
Localization of adipocyte long-chain fatty acyl-CoA synthetase at the plasma membrane. | Q42816411 | ||
Changes in fatty acid transport and transporters are related to the severity of insulin deficiency | Q44095739 | ||
Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36. | Q44155596 | ||
Effects of hyperglycemia on glucose transporters of the muscle: use of the renal glucose reabsorption inhibitor phlorizin to control glycemia | Q44262998 | ||
Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes | Q44480693 | ||
Long-chain fatty acid uptake by skeletal muscle is impaired in homozygous, but not heterozygous, heart-type-FABP null mice | Q44504787 | ||
A null mutation in H-FABP only partially inhibits skeletal muscle fatty acid metabolism | Q44538182 | ||
Overexpression of membrane-associated fatty acid binding protein (FABPpm) in vivo increases fatty acid sarcolemmal transport and metabolism | Q44705297 | ||
Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia | Q44801333 | ||
Fat, carbohydrate, and calories in the development of diabetes and obesity in the C57BL/6J mouse | Q44815335 | ||
Insulin stimulates fatty acid transport by regulating expression of FAT/CD36 but not FABPpm | Q44912770 | ||
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts. | Q45032380 | ||
Effect of exercise on protein kinase C activity and localization in human skeletal muscle | Q45190234 | ||
Impact of altered substrate utilization on cardiac function in isolated hearts from Zucker diabetic fatty rats | Q45199020 | ||
Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy | Q45200908 | ||
Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast | Q45256087 | ||
Effect of elevated lipid concentrations on human skeletal muscle gene expression | Q46575889 | ||
Identification of fatty acid translocase on human skeletal muscle mitochondrial membranes: essential role in fatty acid oxidation | Q46748005 | ||
Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise | Q46853009 | ||
Physiological and pathological roles of a multi-ligand receptor CD36 in atherogenesis; insights from CD36-deficient patients. | Q51498731 | ||
Impaired long-chain fatty acid utilization by cardiac myocytes isolated from mice lacking the heart-type fatty acid binding protein gene. | Q52536097 | ||
In cardiomyocyte hypoxia, insulin-like growth factor-I-induced antiapoptotic signaling requires phosphatidylinositol-3-OH-kinase-dependent and mitogen-activated protein kinase-dependent activation of the transcription factor cAMP response element-bi | Q52961242 | ||
Nongenetic mouse models of non-insulin-dependent diabetes mellitus. | Q54134954 | ||
CD36 Deficiency Rescues Lipotoxic Cardiomyopathy | Q57374829 | ||
The role of hyperglycemia in FAT/CD36 expression and function | Q59768638 | ||
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians | Q60639709 | ||
Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabeticdb/dbmice | Q63199131 | ||
Hypoxia-induced fatty acid transporter translocation increases fatty acid transport and contributes to lipid accumulation in the heart | Q63805175 | ||
Regulation of fatty acid transport: from transcriptional to posttranscriptional effects | Q63805178 | ||
Uptake and tissue content of fatty acids in dog myocardium under normoxic and ischemic conditions | Q70307352 | ||
Association and coexpression of fatty-acid-binding protein and glycoprotein CD36 in the bovine mammary gland | Q71699856 | ||
Myocardial uptake and fractional distribution of palmitate-1 C14 by the ischemic dog heart | Q72811665 | ||
Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy? | Q73088306 | ||
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice | Q73127304 | ||
Long-chain fatty acid-induced changes in gene expression in neonatal cardiac myocytes | Q73338007 | ||
P433 | issue | 1 | |
P921 | main subject | fatty acid | Q61476 |
P304 | page(s) | 12-21 | |
P577 | publication date | 2008-02-01 | |
P1433 | published in | Current cardiology reviews | Q26842280 |
P1476 | title | Protein-mediated Fatty Acid Uptake in the Heart | |
P478 | volume | 4 |
Q36698721 | Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer |
Q92151878 | Barth Syndrome: Exploring Cardiac Metabolism with Induced Pluripotent Stem Cell-Derived Cardiomyocytes |
Q41486927 | Clinical outcomes of real-world patients treated with an amphilimus polymer-free stent versus new generation everolimus-eluting stents. |
Q90651802 | Combined effects of FH (E404D) and ACOX2 (R409H) cause metabolic defects in primary cardiac malignant tumor |
Q88196129 | Cre8™ Unique Technology in Challenging Daily Practice: Proceedings of a satellite symposium held at EuroPCR on 20th - 23rd May 2014 in Paris |
Q90481556 | Distinct cardiac energy metabolism and oxidative stress adaptations between obese and non-obese type 2 diabetes mellitus |
Q64108764 | How Hypertension Affects Heart Metabolism |
Q104465961 | Marein ameliorates Ang II/hypoxia-induced abnormal glucolipid metabolism by modulating the HIF-1α/PPARα/γ pathway in H9c2 cells |
Q88195840 | PCI in Patients with Diabetes: Role of the Cre8 Drug-eluting Stent |
Q88195732 | Patient-tailored Drug-eluting Stent Choice - A Solution for Patients with Diabetes: Proceedings of Two Satellite Symposia Held at EuroPCR in May 2015 in Paris |
Q45462968 | The Implication of PGC-1α on Fatty Acid Transport across Plasma and Mitochondrial Membranes in the Insulin Sensitive Tissues. |
Search more.